Post by
Noteable on Jan 01, 2024 3:55pm
ONCY accumulated deficit (Tax losses applied to a buyout)
ONCY's accumulated deficit a/o September 30, 2023 was approximately $442 million.
ONCY's estimated accumulated deficit a/o December 31, 2023 is approximately $450 Million.
Consequently any buyout offer for ONCY would take into account the accumulated deficit of approximately $0.5 Billion in the price for the company such that a US$ 7.5 Billion offer for ONCY would effectively be approximately US$7 Billion.when taking into account the acquired benefit of the accumulated taxes loss that would come with the acquisition of ONCY.
Comment by
Noteable on Jan 10, 2024 12:44pm
ONCY's estimated accumulated deficit a/o December 31, 2023 is approximately $450 Million
Comment by
Noteable on Jan 25, 2024 11:13am
In comparison to CG Oncology's $380 million raise in their IPO announced on January 25, 2024, ONCY's estimated accumulated deficit a/o December 31, 2023 is approximately $450 Million
Comment by
Noteable on Feb 25, 2024 11:46am
This value of approximately US$ 6.25+ per share a/o December 2023 is a valuation point that will be factored into the calculation of ONCY's comprehensive purchase enterprise value in arriving at the company's starting acquisition price target.
Comment by
Noteable on Mar 09, 2024 1:26pm
https://stockhouse.com/companies/bullboard/t.onc/oncolytics-biotech-ord-shs?postid=35924492 https://stockhouse.com/news/press-releases/2024/03/07/oncolytics-biotech-xae-reports-fourth-quarter-and-full-year-2023-financial
Comment by
Noteable on Feb 16, 2024 2:20pm
The accumulated deficit is worth a minimum of US$ 4.25 per share which clearly demonstrates that ONCY's present share price is being significantly held down, as I have pointed out in previous posts.
Comment by
Noteable on Feb 16, 2024 2:28pm
This accumulated deficit is one of the reasons why analysts covering ONCY have a near term price target of $5+ per share.
Comment by
Noteable on Feb 16, 2024 2:44pm
Should read: "The accumulated deficit represents an underlying value of at least US$ 4.25 per share " ..... which is one of the reasons why analysts covering ONCY have a near term target value of at least $5+ per share.
Comment by
Noteable on Feb 19, 2024 12:33pm
The basic underlying value of ONCY based simply on the company's accumulated deficit, and nothing more, is approximately US $5 per share, which indicates why analysts have a near term target of US$5 per share price, and further indicates that the stock price of ONCY is being significantly throttled by some particular player/s, such as Quentin30 and the team of operatives he identifies with
Comment by
13X2413 on Feb 20, 2024 12:32pm
If 3 or 4 people can affect the price of this stock, this company is in trouble. Stop with the manipulation conspiracy theories. Start living in reality, this stock needs a big kick in the pants. The sooner the better.
Comment by
Noteable on Feb 20, 2024 1:13pm
Wolves in sheeps' clothing come with different messages, but each seek counter the fair value of the company and the share price. Right Canadafan?.
Comment by
Noteable on Feb 20, 2024 6:46pm
Wolves in sheep's clothing come with different messages, but each seeking to counter the fair value of the company and the share price. Right Canadafan? And the other operatives who have recently said that they don't read the stockhouse message board.
Comment by
13X2413 on Feb 20, 2024 7:31pm
Since I'm not a James Bond operative, I'm dying to know what your message is. What makes your operative like opinion worthy of any more belief than other opinions? In my eyes, the others carry more weight as a result of what the ACTUAL value of the stock has done over the past few months. I can't take your FAIR value to the bank.
Comment by
Buckhenry on Feb 20, 2024 9:55pm
Unnoteable needs to put more cologne on his sh!t. He thinks his dung does not stink.
Comment by
armedescapade on Feb 20, 2024 8:30pm
This post has been removed in accordance with Community Policy
Comment by
Noteable on Feb 20, 2024 9:00pm
Only someone like you would seem to know what greedy eyes and little brain means. Perhaps you should switch from eating too many French fries with your greedy little brain like-minded "operatives"
Comment by
armedescapade on Feb 21, 2024 12:42pm
This post has been removed in accordance with Community Policy
Comment by
Buckhenry on Feb 20, 2024 3:18pm
This site is no different than the other stocks I watch. There is an unnoteable for every stock saying that those who don't adhere to his narrative are manipulators. They have to pass the blame to someone else. You can't handle reality.
Comment by
Noteable on Feb 20, 2024 12:32pm
https://www.fiercepharma.com/pharma/fda-approves-iovances-amtagvi-first-cell-therapy-solid-tumor
Comment by
armedescapade on Feb 21, 2024 11:30pm
This post has been removed in accordance with Community Policy
Comment by
armedescapade on Feb 22, 2024 12:57pm
This post has been removed in accordance with Community Policy
Comment by
Azzak34 on Feb 22, 2024 1:12pm
Eeugghh, what a slimy post. Yikes, how many institutional investors do we have? Yikes, what's in our pipeline? Yikes, who says Yikes anymore?
Comment by
armedescapade on Feb 22, 2024 2:52pm
This post has been removed in accordance with Community Policy
Comment by
Azzak34 on Feb 22, 2024 3:01pm
Haha here's my main issue with you folks. Most of your posts read like clues in a cryptic crossword. It's total garbage. It doesn't come off smart, stop trying so hard babe, it's not working. Armedescapade, now what is the meaning behind that moniker you've given yourself. Are you another of the orange man right wing nuts that frequent Stocktwits?
Comment by
Noteable on Feb 22, 2024 8:44pm
It has nothing to do with any tax bracket, as you keep wrongly stating. Read the KPMG opinion.
Comment by
Noteable on Feb 22, 2024 9:46pm
You obviously didn't understand what was said when I wrote the below commentary that the Carryforward Losses do not appky, in diametrically opposed contrast to what you tried to imply. And since a Big Pharma company has profits far in excess of ONCY's accumulated deficit, the following (below referenced) Loss Carryforward provisions do not apply.
Comment by
Noteable on Feb 22, 2024 9:54pm
Furthermore I cited the accounting firm KPMG's opinion on the matter surrounding a corporate acquisition, while you tried to pass off your bewildered understanding of how your accountant handled your personal matter.
Comment by
Noteable on Feb 22, 2024 10:03pm
And US$2.81 per share is what ONCY can raise at its discretion and at anytime by calling its option on the warrants that were tied to the US $15 million deal, thus giving ONCY access to a further US$21 million, whenever ONCY or ONCY's acquirer chooses.
Comment by
Noteable on Feb 22, 2024 10:05pm
Should read "... that were tied to the US $15 million deal Anson Funds Management deal ..."
Comment by
13X2413 on Feb 23, 2024 11:47am
Buyers, where are you???? Doesn't anyone realize that Noteable says the intrinsic value is $5US. Getting close to $1 CDN. now. How can you pass on a deal like this.
Comment by
Quentin30 on Feb 23, 2024 1:13pm
ah I gor it now, thanks Notable... So because ONCY has had 25 years of losses, it's valuable to a company that makes profit... hmmm, And yet still no-one want to buy us...!!
Comment by
Azzak34 on Feb 23, 2024 1:19pm
Haha what a silly Billy you are Quentypoo. Have you ever answered why you keep any shares at all?
Comment by
13X2413 on Feb 22, 2024 8:59pm
$2.81 would be like a lottery win at this point. I'll take it!
Comment by
armedescapade on Feb 22, 2024 10:28pm
This post has been removed in accordance with Community Policy
Comment by
Azzak34 on Feb 23, 2024 3:19am
You know who also talks in these incoherent rambles? Our old friend Stocks4thoughts. Stocks can you produce a codex for the tripe you post please?
Comment by
Lesalpes29 on Feb 23, 2024 7:28am
Until a substantial NR all the talks around a multi billions buyout is futil. It's why I have unstable on ignore... is shooting the same posts weeks after weeks and nothing is moving. This clown is blasting almost everybody even Canadafan... GLTAL